Abbott Laboratories buy BTIG Research
Start price
16.10.25
/
50%
€110.96
Target price
16.10.26
€124.21
Performance (%)
-14.01%
Price
10.03.26
€95.41
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -14.01%. This prediction currently runs until 16.10.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -2.414% | -2.414% |
| iShares Core DAX® | -0.975% | -4.716% |
| iShares Nasdaq 100 | 1.163% | 1.881% |
| iShares Nikkei 225® | -1.593% | -5.385% |
| iShares S&P 500 | -0.278% | 0.327% |
Comments by BTIG_Research for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $145.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by BTIG_Research for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€95.00
18.02.26
18.02.26
€118.19
18.02.27
18.02.27
0.43%
10.03.26
10.03.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€93.02
23.01.26
23.01.26
€119.18
23.01.27
23.01.27
2.57%
10.03.26
10.03.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€107.90
20.11.25
20.11.25
€125.82
20.11.26
20.11.26
-11.58%
10.03.26
10.03.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.68
18.07.25
18.07.25
€124.73
18.07.26
18.07.26
-8.86%
10.03.26
10.03.26